Neuroleptic malignant syndrome (NMS) is a potentially lethal complication of antipsychotic treatment, usually characterized by hyperthermia, rigidity, confusion, diaphoresis, autonomic instability, elevated creatinine phosphokinase (CPK) and leucocytosis.